It is a healthcare private limited company based in Delhi, Delhi, India, established in 2022.
2022 | Delhi, Delhi, India | ActiveGhl Pharma & Diagnostic Private Limited, a active private limited company, was established on 29 June 2022 in Delhi, Delhi, India. Engaging in diagnostic centers & pathology labs within the hospital and medical care sector, it holds CIN: U85110DL2022PTC400942. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹15.00 Cr and a paid-up capital of ₹10.01 Cr.
Formerly known as Global Health Pharmaceutical Private Limited. Employing 170 professional, Its leadership includes Rajdeep Panwar (Manager), Yogesh Kumar Gupta (Director), Naresh Trehan (Director). Past directors included Rajdeep Panwar, Yogesh Kumar Gupta, Sanjeev Kumar. Its latest AGM occurred on 18 September 2025, with the balance sheet filed on 31 March 2025. It is based at E-18 Defence Colony, Delhi, Delhi, 110024.
U85110DL2022PTC400942
400942
29 June 2022
₹15.00 Cr
₹10.01 Cr
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Ghl Pharma & Diagnostic Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rajdeep Panwar | Manager | 01 Jan 2023 | Current |
| Yogesh Kumar Gupta | Director | 20 Mar 2024 | Current |
| Naresh Trehan | Director | 29 Jun 2022 | Current |
| Pankaj Prakash Sahni | Director | 29 Jun 2022 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 18 Sep 2023 | Past |
| Pramod Abcsdd | Additional Director | 16 Sep 2024 | Past |
| Pramod Abcsdd | Director | 15 Dec 2023 | Past |
| Pramod Abcsdd | Cfo | 28 Feb 2023 | Past |
| Pramod Abcsdd | Company Secretary | - | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Ghl Pharma & Diagnostic Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2023, Ghl Pharma & Diagnostic had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Ghl Pharma & Diagnostic has a workforce of 170 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Ghl Pharma & Diagnostic, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ghl Pharma & Diagnostic's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Ghl Pharma & Diagnostic Private Limited last Annual general meeting of members was held on 18 Sep 2025 as per latest MCA records. was completed.
Progress on Mahak was appointed as a Company Secretary was appointed as a Company Secretary on 03 Jun 2025 & has been associated with this company since 5 months 27 days . was documented.
Progress on Ghl Pharma & Diagnostic Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was documented.
The activity Yogesh Kumar Gupta was appointed as a Director was appointed as a Director on 20 Mar 2024 & has been associated with this company since 1 year 8 months . was completed.
Progress on Anup Kumar Jha was appointed as a CFO was appointed as a CFO on 09 Aug 2023 & has been associated with this company since 2 years 3 months . was documented.
Rajdeep Panwar was appointed as a Manager was appointed as a Manager on 01 Jan 2023 & has been associated with this company since 2 years 10 months . was recorded as a recent event.
The CIN of Ghl Pharma & Diagnostic Private Limited is U85110DL2022PTC400942.
Ghl Pharma & Diagnostic Private Limited is headquartered at E-18 Defence Colony, Delhi, Delhi, 110024.
Ghl Pharma & Diagnostic Private Limited was incorporated on 29 June 2022.
The current directors of Ghl Pharma & Diagnostic Private Limited are
The primary industry of Ghl Pharma & Diagnostic Private Limited is Hospital And Medical Care.
Ghl Pharma & Diagnostic Private Limited is unlisted.
The authorized capital of Ghl Pharma & Diagnostic Private Limited is ₹15.00 Cr, and the paid-up capital is ₹10.01 Cr.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX